Discover 1,944 paid clinical trials in Arlington, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,944
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
Location: Fort Worth TX, Houston TX, San Antonio TX, St Louis MO,
Sponsor: Verastem, Inc.
Sex: All
Age: 18+
Code: NCT07644559
Phase 2, Recruiting
A Safety and Efficacy Study of EIK1001 in Combination With Pembrolizumab and Chemotherapy in Participants With Stage 4 Non-Small Cell Lung Cancer.
for
Non Small Cell Lung Cancer (Squamous or Non Squamous),
Location: Fort Worth TX, Daphne AL, Albuquerque NM, Pueblo CO,
Sponsor: Eikon Therapeutics
Sex: All
Age: 18+
Code: NCT07365319
Phase 2, Phase 3, Recruiting
A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)
for
Non-small Cell Lung Cancer (NSCLC)
Location: Fort Worth TX, Denton TX, Tyler TX, Austin TX,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT07361497
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Dose Determining Study of EXS74539 (REC-4539) in Participants With Select Solid Tumors
for
Solid Tumor, Small Cell Lung Cancer (SCLC),
Location: Fort Worth TX, West Valley City UT, Los Angeles CA
Sponsor: Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc.
Sex: All
Age: 18+
Code: NCT07517198
Phase 1, Recruiting
RO7771950 Versus Tucatinib in Combination With Trastuzumab and Capecitabine in People With Locally Advanced or Metastatic Breast Cancer That is Human Epidermal Growth Factor Receptor 2 (HER2)-Positive
for
HER2-positive Breast Cancer
Location: Fort Worth TX, Austin TX, Germantown TN, Huntsville AL,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 18+
Code: NCT07413939
Phase 2, Phase 3, Recruiting
EIK1005-002: A Clinical Research Study Evaluating EIK1005, a Werner Helicase Inhibitor, as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors Including Microsatellite Instability High (MSI-H) Tumors
for
Advanced Solid Tumors, MSI-H or dMMR Advanced Solid Tumors,
Location: Fort Worth TX, Houston TX, Plantation FL, Tamarac FL,
Sponsor: Eikon Therapeutics
Sex: All
Age: 18+
Code: NCT07262619
Phase 1, Phase 2, Recruiting
A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
for
Colorectal Cancer
Location: Fort Worth TX, Grapevine TX, Austin TX, Houston TX,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT07023289
Phase 2, Recruiting
A Phase 1 Study of BMS-986500 as Monotherapy or Combination Therapy in Advanced Solid Tumors
for
Advanced Solid Tumor, Advanced Breast Cancer,
Location: Fort Worth TX, San Antonio TX, St Louis MO,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT06997029
Phase 1, Recruiting
A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Lower Risk Myelodysplastic Syndromes (LR-MDS) Who Need Regular Blood Transfusions
for
Myelodysplastic Syndrome, Anemia
Location: Fort Worth TX, Denton TX, Houston TX, The Woodlands TX,
Sponsor: Takeda
Sex: All
Age: 18+
Code: NCT07422480
Phase 3, Recruiting
FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC
for
Ovarian Cancer, Non-small Cell Lung Cancer
Location: Fort Worth TX, Irving TX, Oklahoma City OK,
Sponsor: Gilead Sciences
Sex: All
Age: 18+
Code: NCT06303505
Phase 1, Phase 2, Recruiting
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
for
Carcinoma, Non-Small-Cell Lung
Location: Fort Worth TX, The Woodlands TX, Houston TX,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT06890598
Phase 3, Recruiting
A Phase 1/2a, First-in-human, Study of BMS-986517 in Participants With Advanced Solid Tumors
for
Solid Tumours
Location: Fort Worth TX, San Antonio TX, Sioux Falls SD,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT07160725
Phase 1, Phase 2, Recruiting
C-Brace Prospective Registry
for
Pareses, Lower Extremity
Location: Fort Worth TX, Dallas TX, Austin TX, Saint Louis MO,
Sponsor: Otto Bock Healthcare Products GmbH
Sex: All
Age: 0+
Code: NCT04640584
Recruiting
Post Market Evaluation of Real World Outcomes and Durability to Support Implantable Inceptiv™ Spinal Cord Stimulation Therapy
for
Chronic Pain, Intractable Pain
Location: Houston TX, San Antonio TX, St Louis MO,
Sponsor: Medtronic
Sex: All
Age: 18+
Code: NCT07507422
Recruiting
New
A Study to Investigate the Safety and Efficacy of KQB368 as Monotherapy in Participants With Advanced Solid Malignancies
for
Advanced Solid Tumors, Colorectal Cancer (CRC),
Location: Dallas TX, Austin TX, San Antonio TX, Nashville TN,
Sponsor: Kumquat Biosciences Inc.
Sex: All
Age: 18+
Code: NCT07542704
Phase 1, Recruiting
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
for
Advanced or Metastatic Solid Tumor
Location: Fort Worth TX, Austin TX, Houston TX, Grand Rapids MI,
Sponsor: Pliant Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06270706
Phase 1, Recruiting
First In Human Study of CX-801 in Advanced Solid Tumors
for
Solid Tumor, Adult
Location: Fort Worth TX, Nashville TN, Englewood CO,
Sponsor: CytomX Therapeutics
Sex: All
Age: 18+
Code: NCT06462794
Phase 1, Recruiting
A Study of IDP-001 in Advanced or Metastatic Solid Tumors
for
Advanced Solid Tumor, Metastatic Solid Tumor,
Location: Fort Worth TX, Indianapolis IN, Sarasota FL, Buffalo NY,